Prescription Information Modernization Act of 2023

This bill allows drug manufacturers to provide FDA-approved prescribing information electronically as the default method, while ensuring prescribers (like doctors and nurses) and dispensers (like pharmacists) can choose to receive paper copies at no extra cost. Manufacturers must offer this paper option permanently and provide requested paper materials promptly. The FDA must issue implementing regulations within one year to detail how healthcare providers can access paper copies, while minimizing economic burdens on providers. The change takes effect two years after enactment or when regulations are finalized, applying to drugs introduced after that date.